Us Bancorp \De\ Charles River Laboratories International, Inc. Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 13,726 shares of CRL stock, worth $2.67 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,726

Previous 21,577 36.39%

Holding current value

$2.67 Million

Previous $4.46 Million 39.35%

% of portfolio

0.0%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$187.96 - $245.29 $1.48 Million - $1.93 Million	-7,851 Reduced 36.39%	13,726 $2.7 Million
Q2 2024 Aug 06, 2024	SELL	$206.39 - $268.73 $46,024 - $59,926	-223 Reduced 1.02%	21,577 $4.46 Million
Q1 2024 May 07, 2024	SELL	$203.52 - $273.43 $582,677 - $782,830	-2,863 Reduced 11.61%	21,800 $5.91 Million
Q4 2023 Feb 09, 2024	SELL	$164.52 - $238.84 $282,809 - $410,565	-1,719 Reduced 6.52%	24,663 $5.83 Million
Q3 2023 Nov 03, 2023	BUY	$194.44 - $217.61 $119,191 - $133,394	613 Added 2.38%	26,382 $5.17 Million
Q2 2023 Aug 09, 2023	SELL	$183.71 - $210.25 $260,684 - $298,344	-1,419 Reduced 5.22%	25,769 $5.42 Million
Q1 2023 May 09, 2023	SELL	$191.89 - $259.92 $1.93 Million - $2.61 Million	-10,037 Reduced 26.96%	27,188 $5.49 Million
Q4 2022 Feb 13, 2023	SELL	$197.11 - $250.07 $80,815 - $102,528	-410 Reduced 1.09%	37,225 $8.11 Million
Q3 2022 Oct 27, 2022	BUY	$182.44 - $250.54 $2 Million - $2.75 Million	10,984 Added 41.21%	37,635 $7.41 Million
Q2 2022 Aug 01, 2022	BUY	$204.13 - $302.4 $29,190 - $43,243	143 Added 0.54%	26,651 $5.7 Million
Q1 2022 May 11, 2022	BUY	$255.51 - $362.11 $622,422 - $882,099	2,436 Added 10.12%	26,508 $7.53 Million
Q4 2021 Feb 11, 2022	BUY	$351.38 - $448.68 $72,032 - $91,979	205 Added 0.86%	24,072 $9.07 Million
Q3 2021 Nov 10, 2021	SELL	$372.64 - $458.3 $35,028 - $43,080	-94 Reduced 0.39%	23,867 $9.85 Million
Q2 2021 Aug 05, 2021	SELL	$294.17 - $371.65 $30,593 - $38,651	-104 Reduced 0.43%	23,961 $8.86 Million
Q1 2021 Apr 28, 2021	BUY	$249.67 - $299.48 $72,903 - $87,448	292 Added 1.23%	24,065 $6.98 Million
Q4 2020 Feb 04, 2021	SELL	$222.0 - $252.62 $259,074 - $294,807	-1,167 Reduced 4.68%	23,773 $5.94 Million
Q3 2020 Nov 10, 2020	SELL	$175.56 - $226.45 $249,997 - $322,464	-1,424 Reduced 5.4%	24,940 $5.65 Million
Q2 2020 Aug 07, 2020	SELL	$118.84 - $189.72 $191,332 - $305,449	-1,610 Reduced 5.76%	26,364 $4.6 Million
Q1 2020 May 13, 2020	BUY	$98.9 - $178.34 $191,569 - $345,444	1,937 Added 7.44%	27,974 $3.53 Million
Q4 2019 Feb 04, 2020	SELL	$126.05 - $152.76 $246,805 - $299,104	-1,958 Reduced 6.99%	26,037 $3.98 Million
Q3 2019 Nov 08, 2019	BUY	$125.07 - $143.67 $65,411 - $75,139	523 Added 1.9%	27,995 $3.71 Million
Q2 2019 Aug 13, 2019	BUY	$123.4 - $148.55 $344,286 - $414,454	2,790 Added 11.3%	27,472 $3.9 Million
Q1 2019 May 08, 2019	SELL	$104.82 - $146.73 $176,202 - $246,653	-1,681 Reduced 6.38%	24,682 $3.59 Million
Q4 2018 Feb 13, 2019	SELL	$105.09 - $137.23 $225,312 - $294,221	-2,144 Reduced 7.52%	26,363 $2.98 Million
Q3 2018 Nov 01, 2018	SELL	$112.11 - $134.54 $15,583 - $18,701	-139 Reduced 0.49%	28,507 $3.84 Million
Q2 2018 Aug 08, 2018	SELL	$102.37 - $117.25 $167,784 - $192,172	-1,639 Reduced 5.41%	28,646 $3.22 Million
Q1 2018 May 08, 2018	BUY	$98.19 - $115.2 $576,080 - $675,878	5,867 Added 24.03%	30,285 $3.23 Million
Q4 2017 Feb 02, 2018	BUY	$100.43 - $118.09 $622,967 - $732,512	6,203 Added 34.05%	24,418 $2.67 Million
Q3 2017 Nov 13, 2017	BUY	$96.72 - $109.26 $1.76 Million - $1.99 Million	18,215	18,215 $1.97 Million

Others Institutions Holding CRL

# of Institutions

696

Shares Held

52.3M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.88B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account